McDermott Acquires Farragut Square Group to Build an Integrated, Data-Driven Life Sciences and Healthcare Advisory Platform

On July 23, 2019, VCBeat (WeChat ID: vcbeat) learned that top healthcare law firm McDermott Will & Emery (“McDermott”) announced the acquisition of healthcare research and consulting firm Farragut Square Group (“Farragut”). Upon completion of the acquisition, Farragut’s regulatory and reimbursement experts will join McDermott, positioning it as a leading healthcare consulting firm with capabilities in policy, communications, and data analytics.

McDermott has more than 20 offices worldwide, with over 1,100 lawyers providing professional services to clients, delivering efficient and precise solutions for clients across industries and geographies. Since 2017, McDermott has been the most active healthcare law firm on the PitchBook rankings.

Farragut is a healthcare research and consulting firm with offices in Washington, D.C., and New York City. Farragut serves private equity investors, bankers, and healthcare entrepreneurs, providing them with expert advisory services on regulatory matters, reimbursement, payment models, and medical audit risks. Recognized as an authoritative resource by institutional investors and other clients, Farragut delivers strategic analysis and remote consulting services. Clients rely on Farragut’s expertise to shape federal and state policy provisions in the United States and to assess reimbursement, payment, and policy trends within the healthcare payment industry.

This merger brings together two companies with highly complementary businesses, creating a great data-driven life and health consulting firm through synergies. The merged McDermott will offer a comprehensive suite of policy advisory services on a single platform, supported by expertise spanning fields from medical technology and life sciences to healthcare services.

“The healthcare sector is constantly evolving, and we are committed to helping our clients act faster to gain a competitive edge,” said Ira Coleman, Chairman of McDermott. “In this vital industry, we will expand our service offerings to serve our clients in novel and innovative ways that best meet their needs.”

“This merger demonstrates our commitment to providing top-tier regulatory, reimbursement, and payment advisory services to investment firms, banks, lenders, and enterprises. Through this combination, we have created an unprecedented life sciences and healthcare consulting firm,” said Alina DiDonato, Co-Founder and CEO of Farragut. “By leveraging data analytics, we can strengthen our already market-leading medical audit capabilities and accelerate the release of research reports.”

This merger has strengthened McDermott’s comprehensive, client-centric healthcare advisory services and expanded the firm’s leadership in consulting within health policy and private equity. Post-merger, McDermott’s core offerings include policy analysis and forecasting, reimbursement and policy trend analysis, communications strategy development, data analytics, regulatory and legislative risk assessment, as well as billing coding and compliance services for medical audit kits.

Whether clients are seeking a “one-stop” service provider or specialized advisory services, the merged McDermott offers a professional platform to meet their evolving consulting needs in the healthcare sector.

(Compiled by: Fan Xin)